Ophthalmology Operation Articles & Analysis
1 news found
(“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced it has initiated a restructuring program to align its resources on later-stage programs in ophthalmology while further extending operating capital into Q1 2023. Strategic Focus Areas UNITY has aligned resources to ...